Building strategic partnerships to advance clinical excellence - our recent collaboration with Sharehereon Health has opened doors to high-quality refractory cancer care at Parkway Shanghai Hospital.
On 1 November, Parkway Shanghai Hospital partnered Professor Ding Gang, Founder of Sharehereon Health, to launch the Parkway Shanghai Hospital Oncology Center and Parkway International Refractory Oncology Consultation Center. This strategic collaboration unifies the expertise and resources of both healthcare organisations to deliver better oncology diagnosis and treatment for cancer patients.
“This strategic partnership is a harbinger of more great things to come. Refractory cancer, which is the cancer resistant to standard treatment, is a high potential segment in the private healthcare space and there’s great promise in it cementing our domain expertise in oncology,” shared Dr Prem Kumar Nair, Group CEO of IHH Healthcare, during his opening address.
Buoyed by this new development, IHH China will continue to innovate clinical practices, foster multidisciplinary cooperation and prioritise holistic patient care, to bring hope and improved outcomes to more cancer patients in Shanghai.
Related Stories
IHH Healthcare Advocates Long-term Sustainability Thinking at Future Economy Conference
At the recent Future Economy Conference 2026, IHH's Group Chief Sustainability Officer Yasemin Tecmen Stubbe shared why sustainability remains critical to business resilience and long-term value creation, particularly amid growing geopolitical uncertainty, climate risks and supply chain disruptions.
IHH Healthcare Aligns Teams in Malaysia and Singapore on Future-ready Healthcare Priorities
IHH Healthcare recently brought together employees across Malaysia’s Southern Region and Singapore for its Country Town Halls, reinforcing the Group’s focus on strengthening current healthcare capabilities while preparing for the evolving needs of the future.
Gleneagles Hong Kong and HKTDC Co-organised a Thematic Session at The Asia Summit on Global Health 2026
Titled “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution”, the thematic panel session co-organised by Gleneagles Hong Kong and Hong Kong Trade Development Council (HKTDC) was moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia.
Acibadem Performed Türkiye's First Experimental 5G‑Supported Remote Robotic Surgical Simulation
The simulation was conducted between Acibadem Maslak Hospital and Acibadem University CASE (Advanced Medical Simulation and Training Center).
Gleneagles JPMC performs first VARIPULSE procedure in Borneo
Cardiovascular Laboratory at Gleneagles JPMC continues to evolve, marked by new milestones in advanced heart rhythm procedures.
Shaping the Future of Oncology at Fortis Cancer Summit 2026
Held on 1–3 May 2026 in New Delhi, the Fortis Cancer Summit 2026 brought together healthcare leaders, oncology experts and clinicians from around the world to exchange insights, strengthen partnerships and shape the future of cancer care.
